Bard Access Systems Recalls Power-Trialysis Slim-Cath Dialysis Catheters
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bard Access Systems, Inc. is recalling 915 units of Power-Trialysis Slim-Cath Short-Term Dialysis Catheters due to a supplier recall of associated lidocaine ampoules manufactured under deficient practices.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Bard Access Systems, Inc. initiated a voluntary recall of certain Power-Trialysis Slim-Cath Short-Term Dialysis Catheters because lidocaine ampoules are being recalled by the supplier due to deficient manufacturing practices.
Which Products Are Affected
The recall affects 915 units distributed worldwide, including U.S. nationwide distribution in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY, and Belgium. Affected products and lots:
- 5855240 Power-Trialysis Slim-Cath Straight Short-Term Dialysis Catheter 12 Fr Triple-Lumen (UDI-DI: 00801741107177, Lot: REKY2412)
- 5855300 Power-Trialysis Slim-Cath Straight Short-Term Dialysis Catheter 12 Fr Triple-Lumen (UDI-DI: 00801741107184, Lot: REKY1364)
- 5865120 Power-Trialysis Slim-Cath Precurved Extension Short-Term Dialysis Catheter 12 Fr Triple-Lumen (UDI-DI: 00801741107191, Lot: RELN0881)
- 5865200 Power-Trialysis Slim-Cath Precurved Extension Short-Term Dialysis Catheter 12 Fr Triple-Lumen (UDI-DI: 00801741107214, Lot: REKY1381)
- 5865240 Power-Trialysis Slim-Cath Precurved Extension Short-Term Dialysis Catheter 12 Fr Triple-Lumen (UDI-DI: 00801741107221, Lot: REJZ0927)
Recall number: Z-2661-2026. Classification: Class II. Event ID: 99096.
What You Should Do
Consumers should refer to the recall notice from Bard Access Systems, Inc. for further instructions.
Why This Matters
The recall involves 915 units of short-term dialysis catheters distributed across the United States and internationally.
Source
FDA recall Z-2661-2026, Bard Access Systems, Inc., Salt Lake City, UT.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,731 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 6, 2026.
Frequently Asked Questions
Common questions about this FDA recall.